<code id='24A9012740'></code><style id='24A9012740'></style>
    • <acronym id='24A9012740'></acronym>
      <center id='24A9012740'><center id='24A9012740'><tfoot id='24A9012740'></tfoot></center><abbr id='24A9012740'><dir id='24A9012740'><tfoot id='24A9012740'></tfoot><noframes id='24A9012740'>

    • <optgroup id='24A9012740'><strike id='24A9012740'><sup id='24A9012740'></sup></strike><code id='24A9012740'></code></optgroup>
        1. <b id='24A9012740'><label id='24A9012740'><select id='24A9012740'><dt id='24A9012740'><span id='24A9012740'></span></dt></select></label></b><u id='24A9012740'></u>
          <i id='24A9012740'><strike id='24A9012740'><tt id='24A9012740'><pre id='24A9012740'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:71872
          mitochondria
          Illustration of mitochondria, powerhouse of the cell. Adobe

          As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. But when they encounter a tumor, something unexpected can happen. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

          A study published this week in Cancer Cell investigated how cancer cells can rob mitochondria from T cells, shutting the immune cell down while energizing themselves. It may be yet another way cancer overcomes both the body’s defenses and resists many immunotherapies like CAR-T therapy and immune checkpoint blockade drugs, experts said.

          advertisement

          “This is a new mechanism of immune evasion. It seems like the cancer cells are draining mitochondria from the T cells,” said Bo Li, a cancer researcher at the University of Pennsylvania and a senior author on the paper. “It’s really amazing. Some of my colleagues, their reaction was like, ‘I can’t believe this is true.’ I understand that. It’s just like the cancer cell is too smart.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          ASCO eve: Let’s set the table for this year's meeting
          ASCO eve: Let’s set the table for this year's meeting

          ThisistheonlineeditionofAdam’sBiotechScorecard,asubscriber-onlynewsletter.STAT+subscriberscansignuph

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          At flashy new research hub, AstraZeneca lays out ambitious growth goals

          PascalSoriothasservedasCEOofAstraZenecasince2012.WinMcNamee/GettyImagesCAMBRIDGE,England—Onabitofaro